Cargando…

Untargeted UPLC-MS Profiling Pipeline to Expand Tissue Metabolome Coverage: Application to Cardiovascular Disease

[Image: see text] Metabolic profiling studies aim to achieve broad metabolome coverage in specific biological samples. However, wide metabolome coverage has proven difficult to achieve, mostly because of the diverse physicochemical properties of small molecules, obligating analysts to seek multiplat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vorkas, Panagiotis A., Isaac, Giorgis, Anwar, Muzaffar A., Davies, Alun H., Want, Elizabeth J., Nicholson, Jeremy K., Holmes, Elaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407508/
https://www.ncbi.nlm.nih.gov/pubmed/25664760
http://dx.doi.org/10.1021/ac503775m
_version_ 1782367919829680128
author Vorkas, Panagiotis A.
Isaac, Giorgis
Anwar, Muzaffar A.
Davies, Alun H.
Want, Elizabeth J.
Nicholson, Jeremy K.
Holmes, Elaine
author_facet Vorkas, Panagiotis A.
Isaac, Giorgis
Anwar, Muzaffar A.
Davies, Alun H.
Want, Elizabeth J.
Nicholson, Jeremy K.
Holmes, Elaine
author_sort Vorkas, Panagiotis A.
collection PubMed
description [Image: see text] Metabolic profiling studies aim to achieve broad metabolome coverage in specific biological samples. However, wide metabolome coverage has proven difficult to achieve, mostly because of the diverse physicochemical properties of small molecules, obligating analysts to seek multiplatform and multimethod approaches. Challenges are even greater when it comes to applications to tissue samples, where tissue lysis and metabolite extraction can induce significant systematic variation in composition. We have developed a pipeline for obtaining the aqueous and organic compounds from diseased arterial tissue using two consecutive extractions, followed by a different untargeted UPLC-MS analysis method for each extract. Methods were rationally chosen and optimized to address the different physicochemical properties of each extract: hydrophilic interaction liquid chromatography (HILIC) for the aqueous extract and reversed-phase chromatography for the organic. This pipeline can be generic for tissue analysis as demonstrated by applications to different tissue types. The experimental setup and fast turnaround time of the two methods contributed toward obtaining highly reproducible features with exceptional chromatographic performance (CV % < 0.5%), making this pipeline suitable for metabolic profiling applications. We structurally assigned 226 metabolites from a range of chemical classes (e.g., carnitines, α-amino acids, purines, pyrimidines, phospholipids, sphingolipids, free fatty acids, and glycerolipids) which were mapped to their corresponding pathways, biological functions and known disease mechanisms. The combination of the two untargeted UPLC-MS methods showed high metabolite complementarity. We demonstrate the application of this pipeline to cardiovascular disease, where we show that the analyzed diseased groups (n = 120) of arterial tissue could be distinguished based on their metabolic profiles.
format Online
Article
Text
id pubmed-4407508
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-44075082015-04-26 Untargeted UPLC-MS Profiling Pipeline to Expand Tissue Metabolome Coverage: Application to Cardiovascular Disease Vorkas, Panagiotis A. Isaac, Giorgis Anwar, Muzaffar A. Davies, Alun H. Want, Elizabeth J. Nicholson, Jeremy K. Holmes, Elaine Anal Chem [Image: see text] Metabolic profiling studies aim to achieve broad metabolome coverage in specific biological samples. However, wide metabolome coverage has proven difficult to achieve, mostly because of the diverse physicochemical properties of small molecules, obligating analysts to seek multiplatform and multimethod approaches. Challenges are even greater when it comes to applications to tissue samples, where tissue lysis and metabolite extraction can induce significant systematic variation in composition. We have developed a pipeline for obtaining the aqueous and organic compounds from diseased arterial tissue using two consecutive extractions, followed by a different untargeted UPLC-MS analysis method for each extract. Methods were rationally chosen and optimized to address the different physicochemical properties of each extract: hydrophilic interaction liquid chromatography (HILIC) for the aqueous extract and reversed-phase chromatography for the organic. This pipeline can be generic for tissue analysis as demonstrated by applications to different tissue types. The experimental setup and fast turnaround time of the two methods contributed toward obtaining highly reproducible features with exceptional chromatographic performance (CV % < 0.5%), making this pipeline suitable for metabolic profiling applications. We structurally assigned 226 metabolites from a range of chemical classes (e.g., carnitines, α-amino acids, purines, pyrimidines, phospholipids, sphingolipids, free fatty acids, and glycerolipids) which were mapped to their corresponding pathways, biological functions and known disease mechanisms. The combination of the two untargeted UPLC-MS methods showed high metabolite complementarity. We demonstrate the application of this pipeline to cardiovascular disease, where we show that the analyzed diseased groups (n = 120) of arterial tissue could be distinguished based on their metabolic profiles. American Chemical Society 2015-02-09 2015-04-21 /pmc/articles/PMC4407508/ /pubmed/25664760 http://dx.doi.org/10.1021/ac503775m Text en Copyright © 2015 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Vorkas, Panagiotis A.
Isaac, Giorgis
Anwar, Muzaffar A.
Davies, Alun H.
Want, Elizabeth J.
Nicholson, Jeremy K.
Holmes, Elaine
Untargeted UPLC-MS Profiling Pipeline to Expand Tissue Metabolome Coverage: Application to Cardiovascular Disease
title Untargeted UPLC-MS Profiling Pipeline to Expand Tissue Metabolome Coverage: Application to Cardiovascular Disease
title_full Untargeted UPLC-MS Profiling Pipeline to Expand Tissue Metabolome Coverage: Application to Cardiovascular Disease
title_fullStr Untargeted UPLC-MS Profiling Pipeline to Expand Tissue Metabolome Coverage: Application to Cardiovascular Disease
title_full_unstemmed Untargeted UPLC-MS Profiling Pipeline to Expand Tissue Metabolome Coverage: Application to Cardiovascular Disease
title_short Untargeted UPLC-MS Profiling Pipeline to Expand Tissue Metabolome Coverage: Application to Cardiovascular Disease
title_sort untargeted uplc-ms profiling pipeline to expand tissue metabolome coverage: application to cardiovascular disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407508/
https://www.ncbi.nlm.nih.gov/pubmed/25664760
http://dx.doi.org/10.1021/ac503775m
work_keys_str_mv AT vorkaspanagiotisa untargeteduplcmsprofilingpipelinetoexpandtissuemetabolomecoverageapplicationtocardiovasculardisease
AT isaacgiorgis untargeteduplcmsprofilingpipelinetoexpandtissuemetabolomecoverageapplicationtocardiovasculardisease
AT anwarmuzaffara untargeteduplcmsprofilingpipelinetoexpandtissuemetabolomecoverageapplicationtocardiovasculardisease
AT daviesalunh untargeteduplcmsprofilingpipelinetoexpandtissuemetabolomecoverageapplicationtocardiovasculardisease
AT wantelizabethj untargeteduplcmsprofilingpipelinetoexpandtissuemetabolomecoverageapplicationtocardiovasculardisease
AT nicholsonjeremyk untargeteduplcmsprofilingpipelinetoexpandtissuemetabolomecoverageapplicationtocardiovasculardisease
AT holmeselaine untargeteduplcmsprofilingpipelinetoexpandtissuemetabolomecoverageapplicationtocardiovasculardisease